Abstract
Catechol-O-methyltransferase (COMT) catalyzes the transfer of a methyl group from Sadenosyl- L-methionine to catechols. Because COMT has an important role in the metabolism of catecholamines, catechol estrogens, and drugs with a catechol moiety such as L-Dopa, measurement of COMT activity in several tissues is important. Furthermore, COMT inhibitors are used clinically in the treatment of Parkinson’s disease, and activation of COMT can control high blood pressure. Hence, high-throughput screening methods for COMT inhibitors and activators are needed. In this methodological article, two analytical methods for the measurement of COMT activity are described. One is very sensitive, and the other is a rapid assay. Norepinephrine, an endogenous compound was used as the substrate, and the enzymatic product (normetanephrine) was quantified with highperformance liquid chromatography-fluorescence or chemiluminescence detection.
Keywords: Chemiluminescence, enzyme, fluorescence, HPLC, Parkinson’s disease, substrate.
Graphical Abstract
Current Biotechnology
Title:Analytical Methods for the Measurement of Catechol-O-Methyltransferase Activity in Animal Tissues
Volume: 4 Issue: 2
Author(s): Makoto Tsunoda
Affiliation:
Keywords: Chemiluminescence, enzyme, fluorescence, HPLC, Parkinson’s disease, substrate.
Abstract: Catechol-O-methyltransferase (COMT) catalyzes the transfer of a methyl group from Sadenosyl- L-methionine to catechols. Because COMT has an important role in the metabolism of catecholamines, catechol estrogens, and drugs with a catechol moiety such as L-Dopa, measurement of COMT activity in several tissues is important. Furthermore, COMT inhibitors are used clinically in the treatment of Parkinson’s disease, and activation of COMT can control high blood pressure. Hence, high-throughput screening methods for COMT inhibitors and activators are needed. In this methodological article, two analytical methods for the measurement of COMT activity are described. One is very sensitive, and the other is a rapid assay. Norepinephrine, an endogenous compound was used as the substrate, and the enzymatic product (normetanephrine) was quantified with highperformance liquid chromatography-fluorescence or chemiluminescence detection.
Export Options
About this article
Cite this article as:
Tsunoda Makoto, Analytical Methods for the Measurement of Catechol-O-Methyltransferase Activity in Animal Tissues, Current Biotechnology 2015; 4 (2) . https://dx.doi.org/10.2174/2211550104666150605222350
DOI https://dx.doi.org/10.2174/2211550104666150605222350 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Lower Urinary Tract Symptoms in Metabolic Syndrome in Young Adults
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of the Stress-Related Anti-Inflammatory Hormones ACTH and Cortisol in Atherosclerosis
Current Vascular Pharmacology The Role of Antioxidants in the Prevention of Cadmium-Induced Endothelial Dysfunction
Current Pharmaceutical Design An Increasing Incidence of Treatment Resistance in Hypertension?
Current Drug Therapy The Effects of Obesity on Drug Metabolism in Children
Drug Metabolism Letters Transdermal Delivery of Diltiazem Hydrochloride from Poloxamer-HPMC Gel: in vitro, ex vivo, and in vivo Studies
Drug Delivery Letters Ovarian Cancer - Angiogenesis and Targeted Therapy
Current Angiogenesis (Discontinued) Renal Endothelial Dysfunction in Acute Kidney Ischemia Reperfusion Injury
Cardiovascular & Hematological Disorders-Drug Targets Genetic Signatures in the Treatment of Stroke
Current Pharmaceutical Design Novel Strategies for the Management of Acute Decompensated Heart Failure
Current Cardiology Reviews Cortisol Regulation in Patients with Type 2 Diabetes and the Metabolic Syndrome
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Fluoroquinolones: Blessings Or Curses
Current Drug Targets Lipid Profile of Children Suffering from Pediatric Rheumatic Diseases (pRDS)
Current Rheumatology Reviews Role of microRNAs in Vascular Remodeling
Current Molecular Medicine Pentraxin 3 Serum Levels in Celiac Patients: Evidences and Perspectives
Recent Patents on Food, Nutrition & Agriculture Moxifloxacin-induced Hypoglycemia in a Non-diabetic Patient
Current Drug Safety Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Current Drug Targets Inhibition of Matrix Metalloproteinases (MMPs) as a Potential Strategy to Ameliorate Hypertension-Induced Cardiovascular Alterations
Current Drug Targets Vascular Endothelial Dysfunction and Nutritional Compounds in Early Type 1 Diabetes
Current Diabetes Reviews Progress in the Diagnosis and Treatment of Pulmonary Aspergillosis
Current Respiratory Medicine Reviews